Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Alfen

Start price
Target price
Perf. (%)
€69.40
17.12.20
€60.00
-2.74%
21.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
ROE higher than 10% per year
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.30
14.12.20
-
14.12.21
169.86%
07.07.21

Probably not worthwhile Investment
buy
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.20
14.12.20
€11.00
14.12.21
15.85%
29.01.21

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
buy
Biocardia Inc.

Start price
Target price
Perf. (%)
€4.53
14.12.20
€5.00
14.12.21
-24.50%
29.01.21

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.90
14.12.20
€2.00
14.12.21
158.23%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
buy
Synlogic Inc.

Start price
Target price
Perf. (%)
€3.00
14.12.20
€3.00
14.12.21
0.00%
29.01.21

Known brand
Could be worthwhile Investment >10% per year
Good culture
Business model of the past or high risk
buy
Navya S.a.

Start price
Target price
Perf. (%)
€3.86
14.12.20
€5.00
14.12.21
-42.05%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Aim Immunotech Inc.

Start price
Target price
Perf. (%)
€1.51
14.12.20
€2.00
14.12.21
-35.89%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Hensoldt AG

Start price
Target price
Perf. (%)
€13.99
13.12.20
-
13.12.21
-11.94%
14.12.21

Leading role in innovation
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Ming Le Sports AG

Start price
Target price
Perf. (%)
€1.27
13.12.20
€1.00
13.12.21
77.95%
03.04.21

Top 10 in its market
Future proof or reliable business model
Good rating
High risks for its business
buy
Up Fintech Holding Ltd.

Start price
Target price
Perf. (%)
€4.74
13.12.20
€28.00
23.10.24
-18.57%
06.01.22

Rainforest Resources Inc.

Start price
Target price
Perf. (%)
€2.08
12.12.20
-
7.69%
15.12.20

Risky Investment
Business model of the past or high risk
Little known brand
thyssenkrupp AG ADR

Start price
Target price
Perf. (%)
€6.15
05.12.20
-
05.12.21
85.37%
27.02.21

Top 10 in its market
Probably not worthwhile Investment
Significant cyclical dependencies
Business model of the past or high risk
buy
Sibanye Stillwater Ltd.

Start price
Target price
Perf. (%)
€3.00
05.12.20
€3.50
05.12.21
-6.36%
06.12.21

Could be very worthwhile Investment >20% year
buy
Fastly Inc.

Start price
Target price
Perf. (%)
€74.50
05.12.20
€75.00
8.05%
08.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Everfuel A/S

Start price
Target price
Perf. (%)
€6.20
28.11.20
-
28.11.21
83.06%
16.02.21

Business model of the past or high risk
Below average Marketposition
Risky Investment
Significant cyclical dependencies
buy
Plastiques Du Val De Loire Sa

Start price
Target price
Perf. (%)
€6.09
28.11.20
€7.00
28.11.21
-3.78%
29.11.21

Could be worthwhile Investment >10% per year
buy
STS Group AG

Start price
Target price
Perf. (%)
€4.82
27.11.20
-
-5.39%
11.12.20

Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
buy
STS Group AG

Start price
Target price
Perf. (%)
€4.61
27.11.20
€5.00
4.56%
27.11.20

Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
buy
Navya S.a.

Start price
Target price
Perf. (%)
€4.50
26.11.20
€5.00
-29.33%
26.01.21

Risky Investment
buy
STS Group AG

Start price
Target price
Perf. (%)
€4.56
25.11.20
€5.00
1.10%
27.11.20

Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
Ecmoho Ltd.

Start price
Target price
Perf. (%)
€2.10
24.11.20
-
24.11.21
-34.76%
02.06.21

Probably not worthwhile Investment
buy
Alfen

Start price
Target price
Perf. (%)
€76.00
24.11.20
€80.00
-8.68%
17.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
ROE higher than 10% per year
buy
Alfen

Start price
Target price
Perf. (%)
€66.90
23.11.20
€70.00
13.60%
24.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
ROE higher than 10% per year
buy
Fastly Inc.

Start price
Target price
Perf. (%)
€71.50
20.11.20
€74.00
4.20%
05.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation